CRISPR 유전체 치료 시장 : 제품 유형별, 용도별, 최종 사용자별, 지역별
CRISPR Genomic Cure Market, By Product Type, By Application, By End User, By Geography
상품코드
:
1741132
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
CRISPR 유전체 치료 시장은 2025년에는 46억 2,000만 달러로 추정되고, 2032년에는 170억 4,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 20.5%를 나타낼 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
시장 규모(2025년) |
46억 2,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR : |
20.50% |
가치 예측(2032년) |
170억 4,000만 달러 |
세계의 CRISPR 유전체 치료 시장은 세계의 생명 공학 산업에서 빠르게 발전하고 있는 분야입니다. 크리스퍼 유전자가위는 유전체 DNA를 정밀하고 지시적으로 변경할 수 있는 혁신적인 유전자 편집 기술입니다. 전례가 없는 정밀도로 유전자를 개변할 수 있는 이 기술은 지금까지 치료 불가능으로 여겨졌던 질병의 치료에 새로운 가능성을 가져왔습니다. 노로지기업과 연구기관과의 협력관계의 확대도 세계의 CRISPR 유전체 치료 시장의 확대에 기여하고 있습니다. 하지만 세계의 CRISPR 유전체 치료 시장은 헬스케어에 혁명을 가져오는 이 기술의 헤아릴 수 없는 가능성에 힘입어 향후 수년간 큰 성장을 이룰 것으로 기대되고 있습니다.
시장 역학 :
만성 질환, 유전성 질환, 감염, 신경 질환, 혈액 질환, 대사성 질환의 유병률 증가, 노인 인구 증가, 안전하고 효과적인 치료 및 요법에 대한 수요 증가, 세포 요법 및 유전자 요법에 대한 자금 증가, 유전자 요법의 빈번한 승인, 새로운 요법의 도입, 세계의 CRISPR 유전체 치료 시장에 대한 사람들의 의식 증가는 예측 기간 동안 세계의 CRISPR 유전체 치료 시장 성장을 증가시킬 것으로 예상되는 주요 요인입니다.
예를 들어, 2021년 3월, 캘리포니아 대학 샌프란시스코, 캘리포니아 대학 버클리교, 캘리포니아 대학 로스앤젤레스교(UCLA)의 과학자들은 환자 자신의 조혈 줄기 세포를 이용한 겸상 적혈구병 환자에 대한 CRISPR 유전자 수정 요법의 초기 단계의 인간 초임상시험을 공동으로 약국(FDA)의 승인을 취득했습니다. 이 치료법은 건강한 골수 기증자로부터의 줄기 세포 이식이라고 하는 현재의 치료법보다 안전하고, 이용하기 쉽고 치유 가능한 치료법을 낳는 것에 의해 겸상 적혈구증의 치료를 일변시킬 가능성이 있습니다. 또한, 이 치료법은 겸상 적혈구증도
본 조사의 주요 특징
- 본 보고서에서는 세계의 CRISPR 유전체 치료 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 설명하고 있습니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 기업의 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 다음 파라미터를 바탕으로 세계의 CRISPR 유전체 치료 시장 주요 기업을 프로파일하고 있습니다.
- 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 세계의 CRISPR 유전체 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 지원합니다.
- 이해관계자는 세계의 CRISPR 유전체 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- 일관된 기회 맵(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
제4장 세계의 CRISPR 유전체 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 세계의 CRISPR 유전체 치료 시장, 제품 유형별(2020-2032년)
- 키트 및 시약
- 라이브러리
- 벡터 설계
- 분석 설계
- 기타
제6장 세계의 CRISPR 유전체 치료 시장, 용도별(2020-2032년)
제7장 세계의 CRISPR 유전체 치료 시장, 최종 사용자별(2020-2032년)
- 바이오 제약회사
- 임상시험수탁기관(CRO)
- 유전자 연구 실험실
- 기타
제8장 세계의 CRISPR 유전체 치료 시장, 지역별(2020-2032년)
- 북미
- 유럽
- 영국
- 독일
- 프랑스
- 스페인
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 인도
- 중국
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카 국가
- 중동
- 아프리카
제9장 경쟁 구도
- Merck KgaA
- Thermo Fisher Scientific Inc.
- Origene Technologies, Inc.
- New England Biolabs
- Intellia Therapeutics, Inc.
- GenScript
- GeneCopoeia, Inc.
- Cellectis
- Mammoth Biosciences
- Precision Biosciences, Inc.
- Synthego Corporation
- CRISPR Therapeutics
- Horizon Discovery Group plc
- Lonza Group Ltd.
- Takara Bio Inc.
제10장 섹션
KTH
영문 목차
CRISPR Genomic Cure Market is estimated to be valued at USD 4.62 Bn in 2025 and is expected to reach USD 17.04 Bn by 2032, growing at a compound annual growth rate (CAGR) of 20.5% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 4.62 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
20.50% |
2032 Value Projection: |
USD 17.04 Bn |
The global CRISPR genomic cure market is a rapidly evolving sector within the global biotechnology industry. CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. This technology has the potential to transform the treatment of a wide range of diseases, including genetic disorders, cancers, and infectious diseases. The market for CRISPR genomic cures is driven by the increasing prevalence of genetic diseases and the growing demand for effective therapies. The technology's ability to modify genes with unprecedented precision has opened up new possibilities for the treatment of diseases that were previously considered untreatable. Moreover, advancements in CRISPR technology, such as the development of more efficient and safer gene-editing tools, are expected to further propel the growth of this market. The increasing investment in research and development activities, coupled with the growing collaboration between biotechnology companies and research institutes, is also contributing to the expansion of the global CRISPR genomic cure market. However, the market faces several challenges, including ethical and safety concerns related to gene editing, regulatory hurdles, and the high cost of developing and commercializing CRISPR-based therapies. Despite these challenges, the global CRISPR genomic cure market is expected to witness significant growth in the coming years, driven by the technology's immense potential to revolutionize healthcare. In conclusion, the global CRISPR genomic cure market represents a promising and dynamic field with the potential to bring about significant advancements in the treatment of various diseases.
Market Dynamics:
Increasing prevalence of chronic disease, genetic disease, infectious diseases, neurological disease, blood disease, and metabolic disease, a growing geriatric population, growing demand for safe and effective treatment or therapies, increasing funding for cell and gene therapies, frequent approvals for gene therapies, the introduction of novel therapies, and increasing awareness among people about the global CRISPR genomic cure market are major factors expected to augment the growth of the global CRISPR genomic cure market during the forecast period.
For instance, in March 2021, scientists at UC San Francisco, UC Berkeley, and UCLA received U.S. Food and Drug Administration (FDA) approval to jointly launch an early-phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells. The therapy has the potential to transform sickle cell disease care by producing an accessible, curative treatment that is safer than the current therapy of stem cell transplant from a healthy bone marrow donor. Moreover, the therapy has the potential to prevent irreversible complications of the disease.
Key features of the study:
- This report provides in-depth analysis of the global CRISPR genomic cure market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global CRISPR genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Origene Technologies, Inc., New England Biolabs, Intellia Therapeutics, Inc., GenScript, GeneCopoeia, Inc., Cellectis, Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, CRISPR Therapeutics, Horizon Discovery Group plc, Lonza Group Ltd., Takara Bio Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global CRISPR genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR genomic cure market
Detailed Segmentation:
- By Product Type:
- Kits & Reagents
- Libraries
- Vector Design
- Assay Design
- Others
- By Application:
- Oncology
- Genetic Diseases
- Genomic Engineering
- Others
- By End User:
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Genetic Research Laboratories
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Origene Technologies, Inc.
- New England Biolabs
- Intellia Therapeutics, Inc.
- GenScript
- GeneCopoeia, Inc.
- Cellectis
- Mammoth Biosciences
- Precision Biosciences, Inc.
- Synthego Corporation
- CRISPR Therapeutics
- Horizon Discovery Group plc
- Lonza Group Ltd.
- Takara Bio Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- CRISPR Genomic Cure Market, By Product Type
- CRISPR Genomic Cure Market, By Application
- CRISPR Genomic Cure Market, By End User
- CRISPR Genomic Cure Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global CRISPR Genomic Cure Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global CRISPR Genomic Cure Market, By Product Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Libraries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Vector Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Assay Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global CRISPR Genomic Cure Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genetic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genomic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global CRISPR Genomic Cure Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genetic Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global CRISPR Genomic Cure Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- UK
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- India
- China
- Japan
- Australia
- South Korea
- ASEAN
- Rest of the APAC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Origene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intellia Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GeneCopoeia, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mammoth Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Precision Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Synthego Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CRISPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Horizon Discovery Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
관련자료
